A detailed history of Ever Source Wealth Advisors, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 302 shares of HRMY stock, worth $7,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
302
Previous 124 143.55%
Holding current value
$7,858
Previous $4,000 125.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$27.94 - $35.91 $4,973 - $6,391
178 Added 143.55%
302 $9,000
Q1 2025

May 13, 2025

SELL
$32.18 - $40.46 $257 - $323
-8 Reduced 6.06%
124 $4,000
Q4 2024

Feb 07, 2025

BUY
$31.86 - $41.49 $1,369 - $1,784
43 Added 48.31%
132 $4,000
Q3 2024

Nov 08, 2024

BUY
$30.0 - $39.95 $1,500 - $1,997
50 Added 128.21%
89 $3,000
Q4 2023

Feb 09, 2024

BUY
$19.2 - $33.78 $748 - $1,317
39 New
39 $1,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.54B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.